John Russell

Lilly posts Q3 loss of $57M, cuts full-year profit guidance

Excluding nonrecurring items, the Indianapolis-based drugmaker posted adjusted earnings of 10 cents a share, beating Zacks consensus estimate of a loss of 11 cents a share.... Read More

IU to spend $250M on new life science institutes in Indy

Indiana University announced Monday afternoon that it plans to invest more than $250 million to create two new science and health research institutes in Indianapolis, recruit life-sciences researchers to Bloomington, and expand or renovate laboratory space at both campuses.... Read More

Eskenazi Hospital to expand therapy dog program with $1M gift

Therapy dogs, a growing area of patient care, are specially trained and certified dogs who visit hospitals, clinics and nursing homes with their owners, and provide comfort and support to people in stressful or anxious situations.... Read More

IU Health Foundation launches $200M fundraising campaign

Indiana University Health Foundation, the fundraising arm of IU Health’s adult hospitals, is launching a $200 million fundraising campaign with the ambitious goal of making Indiana one of the healthiest states in the country.... Read More

Life science boosters hail Indiana’s designation as federal technology hub

Indiana’s life sciences advocates say the state’s new designation as a federal technology hub will position it to compete for millions of dollars and boost the state’s image as a biotech innovator.... Read More

Woman to plead guilty for conspiracy that defrauded Lilly

A Texas woman has agreed to plead guilty to leading a conspiracy to defraud Indianapolis-based drugmaker Eli Lilly and Co. out of more than $600,000 in false prescription savings cards.... Read More

Point Biopharma insiders to reap millions from Lilly deal

Top executives and directors of Indianapolis-based Point Biopharma Global Inc. could rake in an eye-popping $212 million from their deal to sell the company to drugmaker Eli Lilly and Co. Some could also reap millions more in severance pay and stock options.... Read More

New UAW president, a Kokomo native, pushing hard, raising expectations

In just a few months, Shawn Fain has gone from obscurity to one of the most visible leaders in America, pulling, cajoling, demanding that his workers get more concessions from the Big Three automakers after two decades of givebacks.... Read More

Lilly buys radiopharmaceutical startup Point Biopharma for $1.4B

Eli Lilly and Co. is paying Indianapolis-based startup Point Biopharma $12.50 a share, an 85% premium over the company’s closing price on Monday of $6.68 a share.... Read More

FDA rejects Lilly drug for eczema due to inspection issues

Eli Lilly and Co. just hit another bump in the road in its quest to push deeper into treatments for skin diseases, the third setback this year for the Indianapolis-based drugmaker from the U.S Food and Drug Administration.... Read More